Revolution Medicines (RVMD)
(Delayed Data from NSDQ)
$36.63 USD
-0.64 (-1.72%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $36.62 -0.01 (-0.03%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth F Momentum F VGM
Fundamental Charts
About Return on Equity (TTM)
Revolution Medicines, Inc.'s return on equity, or ROE, is -37.06% compared to the ROE of the Medical - Biomedical and Genetics industry of -62.65%. While this shows that RVMD has struggled to make solid use of its equity, this metric will vary significantly from industry to industry.
Return on Equity (or ROE) is calculated as income divided by average shareholder equity (past 12 months, including reinvested earnings). The income number is listed on a company's Income Statement. Shareholder Equity (which is the difference between Total Assets and Total Liabilities) can be found on the Balance Sheet.
RVMD 36.63 -0.64(-1.72%)
Will RVMD be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for RVMD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RVMD
Wall Street Analysts Believe Revolution Medicines (RVMD) Could Rally 90.58%: Here's is How to Trade
Does Revolution Medicines (RVMD) Have the Potential to Rally 74.05% as Wall Street Analysts Expect?
RVMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Keros Therapeutics (KROS) Soars 5.1%: Is Further Upside Left in the Stock?
Down -7.83% in 4 Weeks, Here's Why Revolution Medicines (RVMD) Looks Ripe for a Turnaround
Revolution Medicines (RVMD) Loses -7% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Other News for RVMD
Revolution Medicines Inc (RVMD) Announces Upcoming Q2 2025 Financial Results Release | RVMD ...
Revolution Medicines to Report Financial Results for Second Quarter 2025 After Market Close on ...
Revolution Medicines Inc (RVMD) Unveils Breakthrough in Targeted Cancer Therapy | RVMD stock news
Revolution Medicines (RVMD) Publishes Breakthrough on Zoldonrasib Targeting RAS G12D | RVMD ...
Revolution Medicines Announces Publication of a Peer-Reviewed Research Paper in Science on the ...